Author(s):
Baraa Daghman, Nisrin Kaddar, Mohammed Ayyed Najm, Hala Barakat
Email(s):
baraadaghman@gmail.com
DOI:
10.52711/0974-360X.2024.00720
Address:
Baraa Daghman1, Nisrin Kaddar2, Mohammed Ayyed Najm3, Hala Barakat4
1MD, Department of Pharmaceutical Chemistry and Quality Control, Faculty of Pharmacy, Tishreen University, Lattakia, Syria.
2PhD, Department of Pharmaceutical, Faculty of Pharmacy, Tishreen University, Lattakia, Syria.
3Assistant Professor, College of Medicine, Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq.
4PhD, Department of Pharmaceutical Chemistry and Quality Control, Faculty of Pharmacy, Al-Sham Private University (ASPU), Lattakia, Syria.
*Corresponding Author
Published In:
Volume - 17,
Issue - 10,
Year - 2024
ABSTRACT:
Various geometrical shapes of paracetamol tablets are available, which play an important effect on the speed and quantity of drug release and swallow ability. Patients with swallowing disorders experience difficulties taking large dose (1000mg), which may lead to take two smaller tablets 500mg. This study purposes to investigate the impact of doubling dose and different geometrics on drug release, depending on dissolution test and surface area to volume ratio (SA/V). First, all the studied companies were confirmed to the required constitutional specifications. Then, the dimensions of different shapes of tablets and SA/V ratio were calculated by using Solid Works program. Finally, the dissolution test was performed in a medium of phosphate buffer (pH=5.8) for 30 minutes. All tablets were accepted in term of uniformity of content and weight and showed acceptable friability, with suitable hardness and the disintegration time was less than 30 minutes. After half an hour of beginning the dissolution test, over 80% of the paracetamol from all the tablets examined was found to have been released. The release rates were approximately constant for the various shapes of tablets with the same rate of SA/V. Drug release from two tablets of 500mg was faster than that from one tablet of 1000mg, this offers a therapeutic benefit to achieve the analgesic effect more quickly.
Cite this article:
Baraa Daghman, Nisrin Kaddar, Mohammed Ayyed Najm, Hala Barakat. Comparison of double dose of Paracetamol tablets 500mg with one Paracetamol tablet 1000mg. Research Journal of Pharmacy and Technology. 2024; 17(10):4671-4676. doi: 10.52711/0974-360X.2024.00720
Cite(Electronic):
Baraa Daghman, Nisrin Kaddar, Mohammed Ayyed Najm, Hala Barakat. Comparison of double dose of Paracetamol tablets 500mg with one Paracetamol tablet 1000mg. Research Journal of Pharmacy and Technology. 2024; 17(10):4671-4676. doi: 10.52711/0974-360X.2024.00720 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-10-5
5. REFERENCES:
1. Bhosale, A., S. Hardikar, N. Patil, R. Jagtap, N. Jamdade, and B. Patel. IVIVC and BCS: A Regulatory Perspective. Research Journal of Pharmacy and Technology. 2009. 2(1): 72-79.
2. Souliman, S., S. Blanquet, E. Beyssac, and J.M. Cardot. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form. European Journal of Pharmaceutical Sciences. 2006. 27(1): 72-79. https://doi.org/10.1016/j.ejps.2005.08.006
3. Rao, T.D. and M. Kumar. Analgesic efficacy of paracetamol vs ketorolac after dental extractions. Research Journal of Pharmacy and Technology. 2018. 11(8): 3375-3379. http://dx.doi.org/10.5958/0974-360X.2018.00621.2
4. Zambakjian, C. New Validated Gas Chromatographic Method for the Simultaneous Determination of Ibuprofen and Paracetamol in Bulk and Pharmaceutical Dosage Form. Research Journal of Pharmacy and Technology. 2020; 13(11): 5103-5107. DOI:10.5958/0974-360X.2020.00893.8
5. Mishra, S., P.Y. Mali, A. Kesri, A. Sahu, B. Mishra, and B. Behera. Formulation and in-vitro evaluation of fast dissolving tablets of paracetamol by direct compression technique. Research Journal of Pharmacy and Technology. 2010; 3(3): 934-937.
6. Alhamidi, R. Preparation and Evaluation of Taste Masked Paracetamol Microcapsules. Research Journal of Pharmacy and Technology. 2022; 15(8): 3703-3708. http://dx.doi.org/10.52711/0974-360X.2022.00621
7. Kalantzi, L., C. Reppas, J. Dressman, G. Amidon, H. Junginger, K. Midha, V. Shah, S. Stavchansky, and D.M. Barends. Biowaiver monographs for immediate release solid oral dosage forms: Acetaminophen (paracetamol). Journal of Pharmaceutical Sciences. 2006; 95(1): 4-14. https://doi.org/10.1002/jps.20477
8. Rathnayake, A.D., U. Mannapperuma, D. Thambawita, K.P. Herath, P. Galappatthy, and R.L. Jayakody. Determination of in-vitro Equivalence of Paracetamol Tablets. 2014; 1(1): 75-83. https://doi.org/10.31357/ijms.v1i1.2242
9. Chandrasekhar, K., Manikanda. A new RP-HPLC method development and validation of paracetamol and aceclofenac in tablets by separating diclofenac. Research Journal of Pharmacy and Technology. 2020; 13(9): 4334-4338. http://dx.doi.org/10.5958/0974-360X.2020.00766.0
10. Pujari, A.S., N.A. Gaikwad, I.V. Mane, G.B. Vambhurkar. In-Vitro Evaluation of Different Marketed Brands of Paracetamol Tablets Using Quality Control Tests. 2018; 8(3): 119-122. http://dx.doi.org/10.5958/2231-5713.2018.00019.3
11. Mishra, S., P.Y. Mali, A. Kesri, A. Sahu, B. Mishra. Formulation and in-vitro evaluation of fast dissolving tablets of paracetamol by direct compression technique. Research Journal of Pharmacy and Technology. 2010; 3(3): 934-937.
12. Mamatha, T., M. Raheem, S.I. Pasha. Comparative In-Vitro Evaluation of Marketed Paracetamol Tablets. 2009; 1(2): 100-102.
13. Chabukswar, A.R., V.G. Thakur, D.L. Dharam, M.H. Shah, B.S. Kuchekar, and S.N. Sharma. Development and validation of HPTLC method for simultaneous estimation of paracetamol, ibuprofen and caffeine in bulk and pharmaceutical dosage form. Research Journal of Pharmacy and Technology. 2012; 5(9): 1218-1222.
14. Ghosh, A., U.K. Nayak, P. Rout, T. Nag, and P. Roy. Preparation, Evaluation and in vitro-in vivo Correlation (IVIVC) study of Lamivudine Loaded Microspheres. Research Journal of Pharmacy and Technology. 2008; 1(4): 353-356.
15. Majid, M., R. Mishra, and B.K. Mishra. Effects of various carriers on the solubility of paracetamol. Research Journal of Pharmacy and Technology. 2009; 2(2): 419-420.
16. Naddour, R.F. and N.A. Kaddar. In Vitro Bioequivalence for three Products of Warfarin Sodium in Syrian Market. Research Journal of Pharmacy and Technology. 2018; 11(2): 532-536. http://dx.doi.org/10.5958/0974-360X.2018.00099.9
17. Ratnaparkhi, M.P., S.P. Chaudhari, S.B. Dhiwar, and R.R. Gurav. Marketed Formulations: Quality Evaluation of Conventional Release Paracetamol Tablet. Research Journal of Pharmacy Technology. 2012; 5(3): 390-392.
18. Sayeed, V. Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules Guidance for Industry. US Food Drug Adm. 2015. https://doi.org/10.1016/j.ijpharm.2022.121773
19. Gupta. Mouth dissolving tablets: an insight into challenges and future prospects of technologies in pharmaceutical industries. Research Journal of Pharmacy and Technology. 2022; 15(11): 5068-5077. http://dx.doi.org/10.52711/0974-360X.2022.00852
20. Islahudin, F. Medication adherence and satisfaction among patients in Malaysia. Research Journal of Pharmacy and Technology. 2019. 12(3): p. 1051-1054. http://dx.doi.org/10.5958/0974-360X.2019.00173.2
21. Payot, V., A. Cordonier, J. Marquis, O. Bugnon, K. Hersberger, M. Schneider, and I. Arnet. Prevalence of patients' difficulties in swallowing solid oral dosage forms. in 39th ESCP (European Society of Clinical Pharmacy) European Symposium on Clinical Pharmacy and 13th SFPC (Société Française de Pharmacie Clinique) Congress: Clinical Pharmacy at the Front line of Innovations. 2011.
22. Shariff, Z., D. Kirby, S. Missaghi, A. Rajabi‑Siahboomi, and I. Maidment, Patient-centric medicine design: key characteristics of oral solid dosage forms that improve adherence and acceptance in older people. Pharmaceutics. 2020; 12(10): 905. https://doi.org/10.3390/pharmaceutics12100905
23. Fields, J., J.T. Go, and K.S. Schulze, Pill properties that cause dysphagia and treatment failure. Current Therapeutic Research, 2015; 77: 79-82. https://doi.org/10.1016/j.curtheres.2015.08.002
24. Channer, K.S. and J.P. Virjee, The effect of size and shape of tablets on their esophageal transit. The Journal of Clinical Pharmacology, 1986; 26(2): 141-146. https://doi.org/10.1002/j.1552-4604.1986.tb02922.x
25. Karasulu, H., G. Ertan, and T. Köse, Modeling of theophylline release from different geometrical erodible tablets. European Journal of Pharmaceutics Biopharmaceutics; 2000. 49(2): 177-182. https://doi.org/10.1016/S0939-6411(99)00082-X
26. Ostwal, P.P., Y.L. Jadhav, M.S. Jain, and S.P. Jain, Dissolution profiling of bilayered conventional release paracetamol and sustained release ibuprofen (by simultaneous estimation method UV). Research Journal of Pharmacy and Technology. 2012. 5(4): 490-493.
27. Reynolds, T.D., S.A. Mitchell, and K.M. Balwinski. Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets. Drug Development Industrial Pharmacy. 2002. 28(4): 457-466. https://doi.org/10.1081/DDC-120003007
28. Shammout, H., W. Abdelwahed, and W. Ibrahim. The Effect of Tablet Geometry on Tramadol Hydrochloride Release from Matrix Systems. Bulletin of Pharmaceutical Sciences. Assiut, 2022. 45(1): 1-10. https://doi.org/10.21608/bfsa.2022.239156
29. Martinez, P.R., A. Goyanes, A.W. Basit, and S. Gaisford. Influence of geometry on the drug release profiles of stereolithographic (SLA) 3D-printed tablets. AAPS PharmSciTech. 2018; 19(8): 3355-3361. DOI: 10.1208/s12249-018-1075-3
30. Convention, U.S.P., USP36-NF31. 2012: United States Pharmacopeia.
31. Goyanes, A., P.R. Martinez, A. Buanz, A.W. Basit, and S. Gaisford, Effect of geometry on drug release from 3D printed tablets. International Journal of Pharmaceutics. 2015; 494(2): 657-663. https://doi.org/10.1016/j.ijpharm.2015.04.069
32. Prakash, K., B. Reddy, and V. Sreenivasulu, Effect of tablet surface area and surface area/volume on drug release from lamivudine extended release matrix tablets. International Journal of Pharmaceutical Sciences Nanotechnology. 2010; 3(1): 872-876. https://doi.org/10.37285/ijpsn.2010.3.1.11
33. Te Wierik, G., A. Eissens, J. Bergsma, A. Arends‑Scholte, and G. Bolhuis, A new generation starch product as excipient in pharmaceutical tablets: III. Parameters affecting controlled drug release from tablets based on high surface area retrograded pregelatinized potato starch. International Journal of Pharmaceutics. 1997; 157(2): 181-187. https://doi.org/10.1016/S0378-5173(97)00234-2